CompletedNCT00548002
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
Studying Staphylococcal toxemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Helsinki
- Principal Investigator
- Eeva Ruotsalainen, MDDivision of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
- Intervention
- trovafloxacin and levofloxacin(drug)
- Enrollment
- 430 target
- Eligibility
- 18 years · All sexes
- Timeline
- 1999 – 2002
Study locations (1)
- Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, HUS, Finland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00548002 on ClinicalTrials.govOther trials for Staphylococcal toxemia
Additional recruiting or active studies for the same condition.